Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
References (38)
- et al.
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus ery-thematosus
Lancet
(1983) - et al.
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Lancet
(1990) - et al.
Measurement of anti-phospholipid antibodies by ELISA using b2-glycoprotein I as an antigen
J Immunol Meth
(1991) The antiphospholipid syndrome: ten years on
Lancet
(1993)- et al.
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study
Blood
(1992) - et al.
Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients
Am J Med
(1994) - et al.
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant
Blood
(1986) - et al.
A clinical study of the lupus anticoagulant
Blood
(1976) - et al.
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction and non-hae-morrhagic stroke
Lancet
(1992) - et al.
Anticardiolipin antibodies in an unselected stroke population
Lancet
(1994)
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependendent and b2-glycoprotein l-dependent antiphospholipid antibodies
Blood
(1995)
Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: b2-glycoprotein I (Apolipoprotein H)
Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
Thromb Haemostas
(1991)
Measurement of anticardiolipin antibodies by an enzymelinked immunosorbent assay: standardization and quantitation of results
Clin Exp Immunol
(1986)
Assays for detection of antiphospholipid antibodies
Lupus
(1994)
Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in the systemic lupus erythematosus (SLE) and in non-SLE disorders
Ann Intern Med
(1990)
Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects
Thromb Haemostas
(1994)
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study
Thromb Haemostas
(1991)
Finazzi G
Clinical trials on antiphospholipid syndrome: what is being done and what is needed? Lupus
(1994)
Cited by (401)
Pulmonary embolism and pregnancy
2021, Praticien en Anesthesie ReanimationHematologic Disorders and Stroke
2021, Stroke: Pathophysiology, Diagnosis, and ManagementAntiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis
2020, Seminars in Arthritis and RheumatismCitation Excerpt :However, these statistical findings are limited in interpretation. APL were measured only once in most studies and, where reported, the average IgG aCL titres did not reach the thrombogenic threshold of 40 GPL derived from a multicentre survey on APS patients during the mid 1990′s [40] (though some studies reported few individual values higher than 40 GPL) and. despite the linear relation between IgG aCL and intima media thickness of carotid arteries in APS [41] no atherogenic threshold has ever been detected or calculated.
Antiphospholipid syndrome
2020, Translational ResearchAntiphospholipid antibodies and renal transplant: A systematic review and meta-analysis
2019, Seminars in Arthritis and Rheumatism
Copyright © 1996 Published by Excerpta Medica Inc.